Sam Lee - 18 Jul 2023 Form 4 Insider Report for Cocrystal Pharma, Inc. (COCP)

Role
President and Co-CEO
Signature
/s/ Sam Lee
Issuer symbol
COCP
Transactions as of
18 Jul 2023
Net transactions value
$0
Form type
4
Filing time
20 Jul 2023, 16:05:24 UTC
Previous filing
03 Aug 2022
Next filing
11 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COCP Stock Options (Right to Buy) Award $0 +30,000 $0.000000 30,000 18 Jul 2023 Common Stock 30,000 $2.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were issued pursuant to the 2015 Equity Incentive Plan and are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code (the "Code").
F2 The stock options vest and become exercisable as follows, subject in each case to the limitations on exercisability of incentive stock options under Section 422 of the Code: one-half will vest on July 18, 2024 and the remaining half will vest in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2024, subject to continued employment on each applicable vesting date.